Thiostrepton, a natural product with antibiotic properties isolated from Streptomyces azureus, is known to inhibit the binding of FoxM1 to genomic target sites (28) and cellular studies showed that thiostrepton selectively targets breast cancer cells by inhibiting FoxM1 expression (29). Here, FOXM1 is linked to breast carcinoma.